Objective-Increased expression of human hepatic lipase (HL) or a catalytically inactive (ci) HL clears plasma cholesterol in mice deficient in low-density lipoprotein receptors (LDLr) and murine HL. We hypothesized that increased expression of both HL and ciHL reduces atherosclerosis in these mice. Methods and Results-Mice deficient in both LDLr and murine HL, alone or transgenically expressing similar levels of either human HL or ciHL, were fed a high-fat, cholesterol-enriched "Western" diet for 3 months to accelerate the development of atherosclerosis. Levels of plasma lipids, insulin, glucose, and liver enzymes were measured monthly, and aortic atherosclerosis was quantitated after 3 months. Plasma insulin, glucose, and liver enzyme levels did not differ significantly from controls. After 3 months, expression of HL reduced plasma cholesterol by 55% to 65% and reduced atherosclerosis by 40%. Surprisingly, expression of ciHL did not reduce plasma cholesterol or atherosclerosis. Key Words: hepatic lipase Ⅲ atherosclerosis Ⅲ bridging function Ⅲ fatty liver Ⅲ mouse models H uman hepatic lipase (HL) plays a central role in lipid metabolism and atherosclerosis. 1,2 HL is a secreted, multifunctional enzyme produced by the liver. In the liver, it binds to heparan sulfate proteoglycans (HSPG) on hepatocyte and endothelial cell surfaces and hydrolyzes triglycerides and phospholipids in lipoproteins yielding particles that are optimal for receptor-mediated uptake. 2-5 HL functions as a bridge between lipoproteins and cell-surface HSPG, thereby facilitating receptor-mediated lipoprotein uptake by the lowdensity lipoprotein receptor (LDLr) and the LDLr-related protein (LRP). [5][6][7][8] The bridging also facilitates selective cholesterol uptake by the scavenger receptor B1. 9,10 The role of HL in atherosclerosis is controversial. 11,12 Some studies support a pro-atherogenic role. For example, HL mediates production of small dense LDL (part of the atherogenic lipid profile). HL activity is elevated in males and postmenopausal women, both at increased risk for atherosclerosis. [13][14][15][16] In rabbits transgenic for human apoB, HL expression results in atherogenic small dense LDL particles. 17 In female apoE-deficient mice (an atherosclerosis model), atherosclerosis was reduced when the mouse (m) HL gene was deleted by gene targeting. 18 Furthermore, adding mHL back to macrophages (using bone marrow transplantation) in the apoE-deficient and mHL-deficient mice actually increased atherosclerosis. 19 Other studies support a protective role for HL. In humans, HL reduces atherogenic remnant lipoproteins and increases production of high-density lipoprotein (HDL) 3 and pre- 1 HDL, both avid acceptors of free cholesterol. 20 -24 In HL transgenic mice, aortic cholesterol was decreased. 25 In mice overexpressing HL, cholesterol levels were significantly lower. 5,26 Likewise, animal models overexpressing a catalytically inactive variant of HL (ciHL) (reflecting the bridging function of HL) also had lower cholesterol levels, sugg...